Essex Woodlands Health Ventures

Latest statistics and disclosures from Essex Woodlands Health Ventures's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ABMD, Revance Therapeutics, Corium Intl, Axogen, Entellus Medical Cm, and represent 96.42% of Essex Woodlands Health Ventures's stock portfolio.
  • Reduced shares in these 1 stocks: ABMD (-$84.84M).
  • Essex Woodlands Health Ventures was a net seller of stock by $84.84M.
  • Essex Woodlands Health Ventures has $563.66M in assets under management (AUM), growing by 1.92%.

Companies in the Essex Woodlands Health Ventures portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
ABIOMED (ABMD) 28.32 946818 -34% 168.60
Revance Therapeutics 22.44 4.59M 27.55
Corium Intl 18.39 9.35M 11.08
Axogen 16.69 4.86M 19.35
Entellus Medical Cm 10.58 3.23M 18.46
Endologix (ELGX) 2.03 1.26M 9.08
MediciNova (MNOV) 1.32 1.17M 6.37
Acura Pharmaceuticals 0.16 1.96M 0.45
Catalyst Biosciences 0.07 78622 5.14

Past 13F-HR SEC Filings by Essex Woodlands Health Ventures

View All Filings